[期刊]
  • 《Urologic oncology》 2018年36卷9期

摘要 : Objectives: We aimed to evaluate the prognostic factors for chemotherapy-naive castration-resistant prostate cancer (CRPC) treated with enzalutamide in actual clinical practice using easily accessible clinical variables.

相关作者
相关关键词